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Objectives. We sought to study the relation between passive
smoking at home and the risk of acute myocardial infarction
(AMI).
Background. Previous epidemiologic studies have linked envi-
ronmental tobacco smoke to an increased risk of coronary heart
disease, but the evidence to support this view is not strong enough.
To study this issue further, we analyzed the data from a case-
control study conducted in Argentina between 1991 and 1994.
Methods. Case patients included 336 never-smokers with AMI.
Control patients were 446 never-smokers admitted to the same
network of hospitals with a wide spectrum of acute disorders
unrelated to smoking or to known or suspected risk factors for
AMI. Data on the smoking habits of the participants’ close
relatives (spouse and children) were collected by trained inter-
viewers using a structured questionnaire.
Results. Compared with subjects whose relatives had never
smoked, the multivariate odds ratios for passive smokers, accord-
ing to the smoking status of their relatives, were 1.68 (95%
confidence interval [CI] 1.20 to 2.37) for one or more relatives who
smoked; 1.59 (95% CI 0.85 to 2.96) for a spouse who smoked; 1.24
(95% CI 0.61 to 2.52) for a spouse who smoked 1 to 20 cigarettes/
day; 4.03 (95% CI 0.99 to 16.32) for a spouse who smoked >20
cigarettes/day; and 1.80 (95% CI 1.20 to 2.68) for one or more
children who smoked. There was a significant interaction between
passive smoking and hypercholesterolemia (>2240 mg/dl), hyper-
tension, diabetes and family history of MI.
Conclusions. In never-smokers, passive smoking at home ap-
peared to be associated with the risk of AMI, and ;14% of cases
in men and 18% of cases in women in this Argentinian cohort are
attributable to passive smoking.
(J Am Coll Cardiol 1998;31:797–803)
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The adverse effects of environmental tobacco smoke have
received wide attention in recent years. It is derived from two
sources: 15% from mainstream smoke, which is the smoke
inhaled by the smoker, and 85% from sidestream smoke, which
is the smoke emitted into the surrounding air from the burning
cigarette between puffs (1). Qualitatively, both types of smoke
contain similar components. The difference is in the greater
amount of carbon monoxide, benzopyrene, ammonia and
other carcinogenic compounds that sidestream smoke contains
in relation to mainstream smoke. The principal mechanisms by
which environmental tobacco smoke affects the cardiovascular
system include the reduced ability of the blood to deliver
oxygen to the myocardium and increased platelet activity (2,3).
The clinical effect of these smoke-associated problems has
been consistently studied in several epidemiologic studies. In
healthy nonsmokers, environmental tobacco smoke has been
linked to lung cancer and other diseases of respiratory function
(1,4,5). Moreover, in children of smoking parents, several
studies have consistently demonstrated an increased frequency
of respiratory problems (5). In reference to cardiovascular
disease, which is the principal cause of death in industrialized
countries, an increasing number of studies have shown a
positive relation between passive smoking and the risk of
coronary heart disease (6–17), but there is still uncertainty
regarding this possible association. Although some studies
reported relative risks obtained without appropriate control
for the confounding effects of other major risk factors, other
studies reported weak relations between passive smoking and
cardiovascular disease and still others found relative risk that
was not statistically significant. Moreover, the interaction
between passive smoking and other risk factors for coronary
heart disease has not been investigated.
To provide further information on this topic, this report
presents findings from a large case-control study of myocardial
infarction (MI) conducted in Argentina, whose design enabled
us to control for several other major risk factors for coronary
heart disease.
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Methods
The present study is derived from the Factores de Riesgo
Coronario en Ame´rica del Sur (FRICAS) study, an ongoing
case-control investigation that began in November 1991 of the
risk factors of MI and that is based on a network of medical
centers in 10 countries of South America. The Argentine
branch finished the recruitment of patients in August 1994,
including 1,060 cases with acute MI (AMI) and 1,071 controls,
matched for age, gender and medical center. The present
analysis is based on data collected from this Argentinian
cohort and includes 336 nonsmoker cases and 446 nonsmoker
control subjects who said they had never smoked.
A structured questionnaire was used by trained interviewers
to obtain information on education, habits such alcohol, coffee
and mate (infusion native of South America) consumption,
frequency of consumption of a few selected dietary items, a few
indicators of physical activity, self-reported weight and height,
history of hypertension and family history of MI. The presence
of diabetes was recorded if the subject had been diagnosed or
treated as a diabetic by a doctor before admission to the
medical center. Social class was stratified according the own-
ership of a house or car: low strata with no house or car;
medium strata with a house or car; and high strata with a house
and car. Participants were asked about the smoking status
(nonsmoker, current smoker) of their close relatives (spouse
and children). The number of cigarettes was assessed only for
the spouse. No information was collected on the duration of
smoking and the exposure to tobacco smoke on the job. On
average, ,4% of case and control patients refused to be
interviewed. Furthermore, blood samples were taken by veni-
puncture as soon as possible after admission to the hospital,
both for cases and controls to obtain total serum cholesterol
levels.
Case patients. Case patients included were 336 never-
smokers who had been admitted for a first episode of AMI to
35 coronary care units located in Buenos Aires (capital and
suburbs) and nine provinces of Argentina. Those who had a
history of ischemic heart disease, rheumatic valvular disease,
cardiomyopathy or cardiac surgery were excluded. They were
eligible if they met the standard World Health Organization
criteria for AMI, including pathologic Q waves with evolution,
or any two of the following: a typical history of chest pain for
at least 30 min, electrocardiographic (ECG) changes with
evolution or elevated cardiac enzyme levels (18). The median
age of the cases was 66 years (range 27 to 81).
Control patients. Control patients were never-smokers
identified in the same centers as the cases, but they were
admitted for acute conditions not related to known or sus-
pected risk factors for AMI. All those admitted for cardioce-
rebrovascular, chronic or neoplastic conditions or with a
history of cardiovascular disease were excluded from the
control group. A total of 446 subjects were interviewed; 45%
had traumatic conditions, 30% had surgical conditions and
25% had other miscellaneous illnesses such as acute infections,
dental disorders and disorders of the ear, nose, skin and throat.
The median age of the controls was 65 years (range 24 to 83).
Data analysis. Odds ratios (as estimators of relative risks)
of AMI, together with their 95% confidence intervals, were
first derived from data stratified according to gender and age in
decades, using the Mantel-Haenszel procedure (19,20). To
account for a number of potential confounding factors, uncon-
ditional multiple logistic regression analysis was used. Included
in the regression equation were terms for gender, age (years),
years of education, social class, body mass index (Quetelet’s
index [kg/m2]), cholesterolemia (mg/dl), history of hyperten-
sion and diabetes and family history of AMI (21). The Mantel
extension chi-square test was used to evaluate trends across
strata of increasing dose (21).
Attributable risk proportions were computed by means of
the method described by Bruzzi et al. (22), which provides a
summary attributable risk for multiple factors after allowance
for confounding variables. The method requires the knowledge
of the distribution of exposure to the risk factors only among
case patients, provided that they are representative of the
whole cohort with the disease, and of the odds ratio associated
with the exposure. Statistical analyses were performed using
Statistica/W statistical software (23).
A single-blind test–retest was calculated by two interviewers
using the kappa statistic (24). Eighty-two subjects’ relatives (43
case, 39 control patients) had a telephone interview by a third
interviewer 1 to 4 weeks after their first interview. The global
K index for the 82 patients was 0.69 (0.65 for cases, 0.71 for
controls).
Results
In the overall case-control study data set (1,071 case, 1,060
control patients), the prevalence of smokers was 43% for case
patients and 28% for control patients, and the multivariate
odds ratios of current smokers in relation to nonsmokers was
2.24 (95% confidence interval [CI] 1.83 to 2.75).
The distribution of case and control patients according to
gender, age, social status, exercise, education, body mass index,
history of diabetes and hypertension, hypercholesterolemia
($240 mg/dl) and family history of MI is shown in Table 1.
More case patients were .75 years. Control patients reported
more physical exercise and tended to be more educated than
case patients. Case patients more frequently reported a history
of diabetes, hypertension and hypercholesterolemia and a
family history of MI.
Table 2 shows the distribution of case and control patients
according to the smoking status of their relatives. At least one
relative smoked in 39% of case patients and in 26.2% of
Abbreviations and Acronyms
AMI 5 acute myocardial infarction
CI 5 confidence interval
FRICAS 5 Factores de Riesgo Coronario en Ame´rica del Sur
MI 5 myocardial infarction
OR 5 odds ratio
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control patients; 6.9% of case patients and 6.7% of control
patients reported a spouse who smoked. A spouse who smoked
.20 cigarettes/day was present in 2.4% of case patients
compared with only 0.7% of control patients. Moreover 25.9%
of case patients and 15.7% of control patients reported one or
more children who smoked.
The odds ratios for AMI according to the smoking status of
the subjects’ relatives are reported in Table 3. The risk
Table 1. Distribution of Selected Variables in 336 Case Patients With Acute Myocardial Infarction Who Never Smoked and 446 Control
Patients Who Never Smoked
Men [no. (%) of patients] Women [no. (%) of patients] Total
Case
Patients
Control
Patients
Case
Patients
Control
Patients
Case
Patients
Control
Patients
Age (yr)
,45 7 (4.5%) 26 (11.4%) 3 (1.7%) 6 (2.8%) 10 (3.0%) 32 (7.2%)
45–54 35 (22.4%) 58 (25.4%) 7 (3.9%) 11 (5.0%) 42 (12.5%) 69 (15.5%)
55–64 51 (32.7%) 66 (28.9%) 41 (22.8%) 49 (22.5%) 92 (27.4%) 115 (25.8%)
65–74 31 (19.9%) 59 (25.9%) 65 (36.1%) 92 (42.2%) 96 (28.6%) 151 (33.9%)
$75 32 (20.5%) 19 (8.3%) 64 (35.6%) 60 (27.5%) 96 (28.6%) 79 (17.7%)
Socioeconomic status
Low* 21 (13.5%) 35 (15.4%) 38 (21.1%) 43 (19.7%) 59 (17.6%) 78 (17.5%)
Middle† 60 (38.5%) 87 (38.2%) 106 (58.9%) 126 (57.8%) 166 (49.4%) 213 (47.8%)
High‡ 75 (48.1%) 106 (46.5%) 36 (20.0%) 49 (22.5%) 111 (33%) 155 (34.8%)
Exercise
Yes 138 (88.5%) 183 (80.3%) 167 (92.8%) 199 (91.3%) 305 (90.8%) 382 (85.7%)
No 18 (11.5%) 45 (19.7%) 13 (7.2%) 19 (8.7%) 31 (9.2%) 64 (14.3%)
Education (yr)
,7 39 (25.0%) 46 (20.2%) 58 (32.2%) 46 (21.1%) 97 (28.9%) 92 (20.6%)
7–12 82 (52.6%) 129 (56.6%) 113 (62.8%) 148 (67.9%) 195 (58.0%) 277 (62.1%)
.12 35 (22.4%) 53 (23.2%) 9 (5.0%) 24 (11.0%) 44 (13.1%) 77 (17.3%)
Body mass index (kg/m2)
,25 43 (27.6%) 76 (33.3%) 77 (42.8%) 106 (48.6%) 120 (35.7%) 182 (40.8%)
25–30 87 (55.8%) 110 (48.2%) 61 (33.9%) 79 (36.2%) 148 (44.0%) 189 (42.4%)
.30 26 (16.7%) 42 (18.4%) 42 (23.3%) 33 (15.1%) 68 (20.2%) 75 (16.8%)
Diabetes
No 133 (85.3%) 203 (89.0%) 127 (70.6%) 199 (91.3%) 260 (77.4%) 402 (90.1%)
Yes 23 (14.7%) 25 (11.0%) 53 (29.4%) 19 (8.7%) 76 (22.6%) 44 (9.9%)
Hypertension
No 85 (54.5%) 154 (67.5%) 57 (31.7%) 133 (61.0%) 142 (42.3%) 287 (64.3%)
Yes 71 (45.5%) 74 (32.5%) 123 (68.3%) 85 (39%) 194 (57.7%) 159 (35.7%)
Hypercholesterolemia
No 105 (67.3%) 192 (84.2%) 116 (64.4%) 172 (78.9%) 221 (65.8%) 364 (81.6%)
Yes 51 (32.7%) 36 (15.8%) 64 (35.6%) 46 (21.1%) 115 (34.2%) 82 (18.4%)
Family history of MI
No 108 (69.2%) 200 (87.7%) 113 (62.8%) 174 (79.8%) 221 (65.8%) 374 (83.9%)
Yes 48 (30.8%) 28 (12.3%) 67 (37.2%) 44 (20.2%) 115 (34.2%) 72 (16.1%)
*Does not own house or car. †Owns house or car. ‡Owns house and car. MI 5 myocardial infarction.
Table 2. Prevalence of 336 Case Patients With Acute Myocardial Infarction Who Never Smoked and 446 Control Patients Who Never
Smoked According to the Smoking Status of Their Relatives
Source of Passive Smoke
Men [no. (%) of patients] Women [no. (%) of patients] Total
Patients
Control
Patients Patients
Control
Patients Patients
Control
Patients
No relatives 108 (69.2%) 184 (80.7%) 97 (53.9%) 145 (66.5%) 205 (61.0%) 329 (73.8%)
At least one relative 48 (30.8%) 44 (19.3%) 83 (46.1%) 73 (33.5%) 131 (39.0%) 117 (26.2%)
Spouse 10 (6.4%) 15 (6.6%) 13 (7.2%) 15 (6.9%) 23 (6.9%) 30 (6.7%)
1–20 cigarettes/day 10 (6.4%) 15 (6.6%) 5 (2.8%) 12 (5.5%) 15 (4.5%) 27 (6.1%)
.20 cigarettes/day 0 0 8 (4.4%) 3 (1.4%) 8 (2.4%) 3 (0.7%)
Child 33 (21.2%) 22 (9.6%) 54 (30.0%) 48 (2.2%) 87 (25.9%) 70 (15.7%)
Spouse and child 5 (3.2%) 7 (3.1%) 16 (8.9%) 10 (4.6%) 21 (6.3%) 17 (3.8%)
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increased to 68% (multivariate odds ratio [OR] 1.68, 95% CI
1.20 to 2.37) in nonsmoking subjects with at least one relative
who smoked. The risk increased to 59% in those with a spouse
who smoked. There was a strong positive association between
the number of cigarettes smoked per day by the spouse and the
risk of AMI for the patient, with estimates nearly fourfold for
patients who had a spouse who smoked heavily ($20 ciga-
rettes/day). With one or more children who smoked, the OR
was nearly twofold for the patient (OR 1.80).
The risk of a close relative who smoked increased the risk in
men to 89% and in women to 54% (Table 3). A smoking
spouse increased the risk to 92% in men and to 50% in women,
and one or more children who smoked increased the risk more
than twofold in men (OR 2.30) and 41% in women.
The relation between passive smoking and AMI is further
examined in Table 4 according to gender, age and other major
covariates. The risk estimates for passive smoking were above
the unity in almost all the strata considered. The association
was stronger in those who were referred before diabetes and in
those with a high social status. Likewise, the risk estimates
were particularly high in those with low and high levels of
education. In subjects ,55 years old, the OR was under the
unity (OR 0.84).
Association of passive smoking with other coronary risk
factors. To investigate the interaction between passive smok-
ing and known risk factors, the OR for each of these was
evaluated, both alone and in combination with the presence of
passive smoking (Table 5). The effect on OR was multiplicative
for diabetes and hypercholesterolemia. In those subjects with
diabetes, the OR increased from 1.74 in those with nonsmok-
ing relatives to more than fivefold (OR 5.26) in those with
smoking relatives. Similarly, in those subjects with hypercho-
lesterolemia ($240 mg/dl), the OR increased from 2.03 to
fourfold (OR 4.01) in the absence and presence of passive
smoking, respectively. An additive model was found between
the relation of passive smoking and family history of MI and
hypertension. In those who were referred because of a family
history of MI, the OR increased from 2.57 in those not exposed
to environmental tobacco smoke to more than fourfold (OR
4.08) in those exposed to environmental tobacco smoke, and in
those who reported a history of hypertension, the OR in-
creased from 1.92 to 3.28.
Discussion
This study confirms that passive smoking is an indicator of
risk of AMI. After allowance for other potential confounding
variables, the ORs remained elevated. The presence of one or
more close relatives who smoked increased the risk to ;89% in
men and 54% in women.
Others studies reported an elevated risk of coronary heart
disease in passive smokers. Wells (2) studied the magnitude of
the risk of coronary heart disease in 12 published epidemio-
logic studies; the pooled relative risks of nonfatal coronary
events and of dying of heart disease were 1.3 (95% CI 1.4 to
1.6) and 1.2 (95% CI 1.1 to 1.4), respectively. Only two of these
studies, which had controlled for confounding variables that
included the principal known and suspected risk factors for
coronary heart disease, showed significant statistically ORs.
Hole et al. (10), in a prospective study in Scotland, found a
relative risk of mortality from ischemic heart disease of 2.01
(95% CI 1.21 to 3.35). In Georgia, a prospective study of up to
20 years of follow-up of 513 women .40 years old, showed an
increased risk of mortality from coronary heart disease (OR
1.59, 95% CI 0.99 to 2.57) (12).
Two recent case-control studies examined the effect of
passive smoking on cardiovascular disease. La Vecchia et al.
(14) reported a multivariate relative risk of AMI of 1.21 (95%
CI 0.57 to 2.52) for those subjects married to a current smoker
in relation to those with a spouse who never smoked. In China,
Table 3. Odds Ratios (95% confidence intervals) for Acute Myocardial Infarction in 336 Case Patients Who Never Smoked and 446 Control
Patients Who Never Smoked According to the Smoking Status of Their Close Relatives
Source of Passive
Smoke
Men [OR (95% CI)] Women [OR (95% CI)] Total [OR (95% CI)]
MH* MLR† MH* MLR† MH‡ MLR†
No relatives (ref no.) 1 1 1 1 1 1
One or more relatives 1.84 1.89 1.71 1.54 1.76 1.68
(1.10–3.09) (1.13–3.18) (1.11–2.64) (0.95–2.51) (1.28–0.45) (1.20–2.37)
Spouse 1.34 1.92 1.41 1.50 1.37 1.59
(0.51–3.49) (0.76–4.84) (0.59–3.39) (0.62–3.60) (0.73–2.59) (0.85–2.96)
1–20 cigarettes/day — — 0.69 0.90 1 1.24
(0.20–2.19) (0.28–2.86) (0.48–2.07) (0.61–2.52)
.20 cigarettes/day — — 4.83 3.31 4.83 4.03
(1.01–22.45) (0.77–14.17) (1.1–22.45) (0.99–16.32)
Child 2.31 2.30 1.66 1.41 1.88 1.80
(1.21–4.42) (1.21–4.35) (1.01–2.77) (0.81–2.44) (1.28–2.80) (1.20–2.68)
Spouse and child 1.31 0.65 2.55 2.50 2.06 1.45
(0.34–4.85) (1.16–2.59) (1.06–6.69) (0.95–6.59) (1.01–4.34) (0.68–3.1)
*Mantel-Haenszel (MH) estimates adjusted for age in decades. †Estimate for multiple logistic regression (MLR) equations, including terms for age, gender,
cholesterolemia (mg/dl), diabetes, hypertension, body mass index, years of education, social status, exercise and family history of myocardial infarction.
‡Mantel-Haenszel estimates adjusted for age in decades and gender. CI 5 confidence interval; OR 5 odds ratio; ref 5 reference.
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He et al. (15) assessed data from nonsmoking females: 59 with
coronary heart disease and 126 control subjects. After adjust-
ment for age, hypertension, type A personality, cholesterol and
high density lipoprotein cholesterol level, the ORs for passive
smoke from husband and co-workers were 1.24 (95% CI 0.56
to 2.72) and 1.85 (95% CI 0.86 to 4.00), respectively. Data from
two other large, prospective cohort studies also support the
evidence of an association between environmental tobacco
smoke and coronary heart disease. Steenland et al. (16) found
that after adjustment for other coronary risk factors, passive
smoking increased the risk of coronary heart disease to 22% in
men and to 10% in women. Kawachi et al. (17) examined the
effect of environmental tobacco smoke in 32,046 nonsmoking
women over a period up to 10 years. The relative risk of total
coronary heart disease was 1.58 among women reporting
occasional exposure and 1.91 among those reporting regular
exposure.
Thus, the present results are in agreement with most
findings of case-control and cohort studies, confirming that
passive smoking may play an important role in the ischemic
manifestation of coronary artery disease in different popula-
tions with different risk factor exposure characteristics. Like-
wise, these findings confirm that the association was apprecia-
bly stronger in both genders and in various strata of selected
covariables.
The finding of a dose response with the number of ciga-
rettes smoked per day by the spouse adds weight to the
possibility of environmental tobacco smoke being causally
related to the development of AMI. This linear direct trend
relation that we found confirms the observation from several
studies, including the Multiple Risk Factor Intervention Trial
(8), a Scottish study (10), a Chinese study (15) and the Nurses’
Health Study (17). Others studies, however, found no linear
Table 4. Odds Ratios* (and 95% confidence intervals) for Acute
Myocardial Infarction in Relation to Smoking Status of Close
Relatives by Strata of Selected Covariates
OR (95% CI) of Passive Smoking
According to
No Relatives
(ref value)
At Least One
Relative
Gender
Male 1 1.89 (1.13–3.18)
Female 1 1.54 (0.95–2.51)
Age (yr)
$55 1 1.87 (1.28–2.72)
,55 1 0.84 (0.34–2.04)
Exercise
No 1 1.67 (1.17–2.40)
Yes 1 1.85 (0.48–7.17)
Education (yr)
,7 1 3.27 (1.56–6.88)
7–12 1 1.20 (0.77–1.88)
.12 1 4.24 (1.35–13.28)
Socioeconomic status
Low† 1 1.60 (1.06–2.43)
Middle† 1 2.08 (1.29–3.39)
High† 1 3.32 (1.31–8.44)
Body mass index (kg/m2)
,25 1 1.84 (1.03–3.28)
25–30 1 2.24 (1.30–3.85)
.30 1 0.68 (0.26–1.76)
Diabetes
No 1 1.57 (1.07–2.29)
Yes 1 3.33 (1.29–8.58)
Hypertension
No 1 1.79 (1.11–2.91)
Yes 1 1.59 (0.97–2.62)
Hypercholesterolemia ($240 mg/dl)
No 1 1.58 (1.05–2.29)
Yes 1 2.18 (1.06–4.49)
Family history of MI
No 1 1.70 (1.15–2.52)
Yes 1 1.81 (0.86–3.82)
*Estimates are from multiple logistic regression equations, including terms
for age, gender, cholesterolemia, diabetes, hypertension, body mass index, years
of education, socioeconomic status, exercise and family history of myocardial
infarction (MI). †As defined in Table 1. Other abbreviations as in Table 3.
Table 5. Odds Ratios* (and 95% confidence intervals) for
Interaction Between Passive Smoking and Other Selected Risk
Factors for Acute Myocardial Infarction
OR (95% CI) of Passive Smoking
According to
No Relatives
At Least
One Relative
Body mass index (kg/m2)
,25 1† 1.97
(1.15–3.39)
25–30 1.13 2.57
(0.73–1.75) (1.46–4.54)
.30 1.59 1.19
(0.90–2.82) (0.60–2.35)
Diabetes
No 1† 1.51
(1.04–2.19)
Yes 1.74 5.26
1.01–3.00 (2.44–11.36)
Hypertension
No 1† 1.65
(1.03–2.65)
Yes 1.92 3.28
(1.30–2.83) (2.02–5.34)
Hypercholesterolemia ($240 mg/dl)
No 1† 1.60
(1.08–2.34)
Yes 2.03 4.01
(1.32–3.12) (2.17–7.40)
Family history of MI
No 1† 1.71
(1.16–2.53)
Yes 2.57 4.08
(1.66–4.00) (2.16–7.70)
*Estimates are from multiple logistic regression equations, including terms
for age, gender, cholesterolemia (mg/dl), diabetes, hypertension, body mass
index, years of education, socioeconomic status, exercise and family history of
myocardial infarction. †Reference value. Abbreviations as in Tables 1 and 3.
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relation, including a British study (7), a prospective study from
Maryland (9) and the American Cancer Society cohort study
(16). The inclusion of too few patients in the British study, or
inadequate control for changes in the amount of cigarettes
smoked during the follow-up period of cohort studies, may well
have flattened or distorted the slope of the relation.
In this study, the combined exposure of passive smoking
with other coronary risk factors raised the AMI risk. These
interactions strongly suggest a synergism between environmen-
tal tobacco smoke and other coronary risk factors: to an
additive model when passive smoking was associated with
hypertension or a family history of MI and to a multiplicative
model when the association was with diabetes or hypercholes-
terolemia. These samples of synergy were not analyzed in other
studies of passive smoking and coronary heart disease and
suggest important direction for further investigations.
Strengths and limitations of the study. Among the strengths
of this study are the almost complete participation, with only
4% of subjects refusing to participate, and the comparability
between recruitment areas of case and control patients.
Using a case-control design, we were able to collect infor-
mation on risk factors for AMI from a large sample in a short
period, controlling for major, identified potential confounding
factors.
Short-term exposure to environmental tobacco smoke re-
sults in increased platelet sensitivity and a decreased ability of
the heart to receive and process oxygen (2). A case-control
study design may be particularly appropriate to investigate the
passive smoking–AMI relation, if this reflects a short-term
effect on risk. In fact, it may provide more accurate informa-
tion on passive smoking during a short time before occurrence
of AMI than cohort investigations, which generally obtain
information on smoking exposure years or even decades before
disease onset.
Most studies that linked environmental tobacco smoke at
home with coronary heart disease obtained information on the
spouse’s smoking habits (6–8,12,14,15) and others reported
exposure with someone else at home (9–11,13,17) without
identifying the subject. None obtained data on other close-
contact relatives’ habits. In our study, we observed that the risk
of AMI was increased to 80% in those with a child who
smoked. These results are of particular interest and may offer
more reassuring evidence than data previously available in
terms of more general epidemiologic inference.
A potential limitation of this study is that patients with AMI
had to survive long enough to be interviewed and therefore
may not have been representative of all patients with AMI.
Nonetheless, it seems unlikely that the exclusion of patients
who died before or soon after admission to the hospital for a
first AMI would have affected our findings, because the
relation of passive smoking to fatal disease appears quite
similar to its relation to nonfatal illness. The association
between passive smoking and AMI was observed in other
prospective studies of both fatal and nonfatal AMI.
Another limitation of the present study design was that
information was based only on self-reporting. However, such
information bias is likely to be similar for both case and control
patients and should dilute the strength of the association to the
same extent.
Although this study shows that passive smoking is associ-
ated with an increased risk of AMI, the OR was lower for
younger subjects; however, the wide confidence interval (95%
CI 0.34 to 2.04) does not allow any definitive conclusion on this
issue.
Conclusions. These results indicate that passive smoking at
home increase the risk of AMI. If the observed association is
real, in terms of population attributable risk, .14% of first
episodes of AMI in men who never smoked and 18% in women
who never smoked in Argentina could be avoided by prevent-
ing passive smoking at home. These results underline the
importance of new public health policy against environmental
tobacco smoke, to make a real impact on the control of
coronary heart disease in various areas of the world, especially
in developing nations in which tobacco consumption is increas-
ing.
We thank Charles Hennekens, MD, for the revision of the manuscript.
Appendix
Argentine Factores de Riesgo Coronario en Ame´rica
del Sur (FRICAS) Investigators
Steering Committee: H. Schargrodsky, M. Ciruzzi, P. Pramparo, J.
Rozlosnik.
Coordinating Committee: B. Abecasis, C. Brenner, J. Ce´sar, H. Delmonte,
O. Esteban, B. Labonia, H. Montagna, C. Paterno, V. Rudich, S. Soifer, J.
Tartaglione
Participating Centers: Buenos Aires (Capital)—Alema´n Hospital: D. Siskos;
Argerich Hospital: S. Centeno; Churruca Hospital: D. Galva´n, S. Cherkerdemian;
Ferna´ndez Hospital: C. Nejamsky, D. Rigou; Israelita Hospital: A. Kiezelstein, S.
D’agostino, A. Bronstein; Italiano Hospital: V. Rudich, R. Oliveri; Pirovano
Hospital: I. Luluaga, H. Zylberstejn, M. Fortunato, P. Soria, J. La´zzari; Zubi-
zarreta Hospital: C. Brenner, Y. Plotquin; Anchorena Medical Center: E. Mele, L.
Quintana; Guemes Medical Center: R. Ahuad; Hacienda Medical Center: M.
Haquim; Mater Dei Medical Center: R. Calvino, O. Iavicoli; Me´ndez Medical
Center: A. Monetti, L. Eda, B. Kogan; Trinidad Medical Center: M. Festa, B.
Fromen; Clı´nica Del Sol Medical Center: E. Esparza Iraola, C. Taquini. Buenos
Aires (Provinces)—La Matanza Hospital: C. Rodrigo; San Isidro Hospital: D.
Romero Matos; Posadas Hospital: B. Abecasis; San Juan de Dios Hospital: B.
Abecasis. Bahı´a Blanca (City): O. Camou, D. Solı´s. Coronel Sua´rez (City): A.
Caccavo. La Plata (City): R. De Marco, P. Pardo. Tres Lomas (City): A. Alfonso.
Corrientes: J. Vaccaro, Entre Rı´os (Concordia): J. De la Cruz Ojeda. Jujuy (San
Salvador De Jujuy): R. Peleteiro, G. Bustamante. Misiones (Posadas): S.
Castillo. Neuque´n (San Martı´n De Los Andes): G. Pichel. Rio Negro (Viedma):
R. Coniglio. Santa Fe (Rosario): D. Piskorz, R. Grisolia, C. Girino, M. Mancini.
Tucuma´n (San Miguel De Tucuma´n): J. De Rosa, J. Waisman.
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